Browse by Audience
Skip to content
Papers of the Week
Improvements across a range of patient-reported domains with fremanezumab treatment: results from a patient survey study.
Abstract
The long-term safety and efficacy of fremanezumab were evaluated in a 52-week extension study (NCT02638103). Patient satisfaction with fremanezumab, dosing preferences, and patient-reported outcomes were assessed in a subpopulation who completed the extension study and consented to a follow-up questionnaire.